###begin article-title 0
###xml 51 59 <span type="species:ncbi:9606">patients</span>
Presence of myocilin sequence variants in Japanese patients with open-angle glaucoma
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 62 70 <span type="species:ncbi:9606">patients</span>
###xml 150 158 <span type="species:ncbi:9606">patients</span>
To examine the myocilin (MYOC) gene for mutations in Japanese patients with primary open-angle glaucoma (POAG) and to determine the phenotypes of the patients with the mutations.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 44 52 <span type="species:ncbi:9606">patients</span>
One-hundred thirty-eight unrelated Japanese patients with POAG were studied. Genomic DNA was extracted from leukocytes of peripheral blood, and the three coding exons including the intron-exon boundaries were amplified by polymerase chain reaction (PCR) and directly sequenced bi-directionally.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 270 273 <span type="species:ncbi:9606">man</span>
###xml 393 401 <span type="species:ncbi:9606">patients</span>
Two sequence variants were identified, one novel non-synonymous amino acid change (p.Gln297His) and one reported synonymous amino acid change (p.Ala363Thr). These mutations were not detected in the 118 ethnically-matched controls. p.Gln297His was found in a 70-year-old man, who developed POAG at a late age, and his intraocular pressure was high. p.Ala363Thr was found in two cases, and both patients developed POAG at an early age and had high intraocular pressures that responded poorly to medical treatment.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
Two non-synonymous variants, p.Gln297His and p.Ala363Thr, indicate that they are involved in the pathogenesis of POAG. p.Ala363Thr has been found in another Japanese population and would be useful in genetic testing.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 328 329 328 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 330 331 330 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 519 520 519 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
Primary open-angle glaucoma (POAG) is a genetically heterogeneous disorder characterized by a progressive excavation of the optic disc and a loss of retinal nerve fiber leading to visual field defects. It is most likely a genetically heterogeneous disorder caused by the interaction of multiple genes and environmental factors [1,2]. Adult onset POAG is inherited as a complex trait while juvenile onset open-angle glaucoma (JOAG) has an early onset with high penetrance and an autosomal dominant mode of transmission [3].
###end p 11
###begin p 12
###xml 124 128 124 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 158 162 158 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 170 171 170 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 203 208 203 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 216 217 216 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 233 237 233 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 378 379 378 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 380 381 380 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 427 431 427 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 529 533 529 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 567 568 567 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 602 604 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 605 607 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 610 614 610 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 788 789 788 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 790 791 790 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 792 793 792 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 794 796 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
To date, at least 14 loci from GLC1A to GLC1N have been linked to POAG, and three genes have been identified, the myocilin (MYOC) gene [4,5], the optineurin (OPTN) gene [6], and the WD repeat domain 36 (WDR36) gene [7]. Mutations of MYOC have been found in sporadic and familial cases of POAG worldwide, and their specific phenotype-genotype correlation has been characterized [5,8-24]. Overall, 2%-4% of POAG cases are due to MYOC mutations [10,15], although it might be as high as 22.2% [20] to 36% [18] in families with JOAG. MYOC encodes 504 amino acid residues [8] and is composed of three exons [25,26]. MYOC contains a myosin-like domain and an olfactomedin-like domain, and about 90% of the mutations are clustered in the region coding for the olfactomedin-like domain in exon 3 [5,8,9,11].
###end p 12
###begin p 13
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
The types of mutations found in diverse ethnic populations are different, but the overall incidence of myocilin mutations is similar, which is about 2%-4% in all populations [15]. The most common mutation of MYOC is the p.Gln368Stop, which is found in Caucasians [12] and has not been detected in Japanese. This would suggest that the mutations in MYOC in the Japanese could be different from that of Caucasians and perhaps other ethnic populations.
###end p 13
###begin p 14
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 43 49 43 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36)</italic>
###xml 119 123 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 297 301 297 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 328 336 <span type="species:ncbi:9606">patients</span>
###xml 416 424 <span type="species:ncbi:9606">patients</span>
For the other two glaucoma genes (OPTN and WDR36), the results of the screening were difficult to interpret. Thus, the MYOC gene is the only glaucoma gene that has been widely evaluated and is accepted to be a causal gene for glaucoma in many populations. The purpose of this study was to examine MYOC for mutations in Japanese patients with primary open-angle glaucoma (POAG) and to determine the phenotypes of the patients with these mutations.
###end p 14
###begin title 15
Methods
###end title 15
###begin p 16
###xml 44 52 <span type="species:ncbi:9606">patients</span>
###xml 67 70 <span type="species:ncbi:9606">men</span>
###xml 78 83 <span type="species:ncbi:9606">women</span>
###xml 270 278 <span type="species:ncbi:9606">patients</span>
One-hundred thirty-eight unrelated Japanese patients with POAG (72 men and 66 women; mean age 63.6+/-14.4 years), who were examined at the Ophthalmic Clinic of the Tohoku University Hospital, Sendai, Japan, were studied. The purpose and procedures were explained to all patients, and an informed consent was obtained. This study was approved by the Tohoku University Institutional Review Board, and the procedures used conformed to the tenets of the Declaration of Helsinki.
###end p 16
###begin p 17
###xml 54 62 <span type="species:ncbi:9606">patients</span>
###xml 100 107 <span type="species:ncbi:9606">patient</span>
###xml 546 554 <span type="species:ncbi:9606">patients</span>
###xml 566 574 <span type="species:ncbi:9606">Patients</span>
Routine ophthalmic examinations were performed on all patients. The criteria used for classifying a patient as having POAG were as follows: 1) applanation intraocular pressure (IOP) greater than 22 mmHg in each eye; 2) glaucomatous cupping in each eye including a cup-to-disc ratio greater than 0.7, 3) visual field defects determined by Goldmann perimetry and/or Humphrey field analyzer consistent with the glaucomatous cupping in at least one eye, and 4) an open anterior chamber angle. The mean IOP at diagnosis was 27.2+/-5.1 mmHg in the 138 patients with POAG. Patients with secondary glaucoma caused by trauma, uveitis, or steroid-induced were excluded.
###end p 17
###begin p 18
###xml 21 24 <span type="species:ncbi:9606">men</span>
###xml 32 37 <span type="species:ncbi:9606">women</span>
###xml 272 280 <span type="species:ncbi:9606">patients</span>
Control subjects (62 men and 56 women; mean age 68.0+/-7.7 years) had the following characteristics: 1) an IOP of less than 22 mmHg, 2) normal optic discs, and 3) no family history of glaucoma. The mean IOP at the initial examination was 14.3+/-3.4 mmHg in the118 control patients.
###end p 18
###begin p 19
###xml 306 313 306 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 477 479 471 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 599 601 593 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
Genomic DNA was extracted from peripheral blood leukocytes and purified with the Qiagen QIAamp Blood Kit (Qiagen, Valencia, CA). All three exons that code for a 504 amino acid protein were amplified by olymerase chain reaction (PCR). For the PCR, seven primer sets were used under standard PCR conditions (Table 1). The amplifications were performed at 58 degreesC annealing temperature. PCR fragments were purified by ExoSAP-IT (USB, Cleveland, OH) and sequenced by the BigDyeTM Terminator Cycle Sequencing Ready Reaction Kit (Perkin-Elmer, Foster City, CA) on an automated DNA sequencer (ABI PRISMTM 3100 Genetic Analyzer, Perkin-Elmer).
###end p 19
###begin title 20
Primer sequences used in this study.
###end title 20
###begin p 21
###xml 161 163 155 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 283 285 277 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
The amplifications were performed at 58 degreesC annealing temperature. PCR fragments were purified by ExoSAP-IT (USB, Cleveland, OH) and sequenced by the BigDyeTM Terminator Cycle Sequencing Ready Reaction Kit (Perkin-Elmer, Foster City, CA) on an automated DNA sequencer (ABI PRISMTM 3100 Genetic Analyzer, Perkin-Elmer).
###end p 21
###begin title 22
Results
###end title 22
###begin p 23
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
Our results showed two MYOC variants. The first was a novel MYOC variant, a missense mutation at the third nucleotide in codon 297 (CAG>CAC) resulting in an amino acid substitution of glutamine by histidine (p.Gln297His). The second variant was a reported MYOC variant, a missense mutation at the first nucleotide of codon 363 (GCT>ACT) resulting in an amino acid substitution of alanine by threonine (p.Ala363Thr) [24]. These mutations were not detected in all normal controls.
###end p 23
###begin title 24
Case 1 (p.Gln297His)
###end title 24
###begin p 25
###xml 25 28 <span type="species:ncbi:9606">man</span>
Case 1 was a 71-year-old man diagnosed with POAG at the age of 60 years. He has three brothers and four sisters, but none of them has a glaucoma history. His IOP at the time of diagnosis was 28 mmHg Oculus Dexter (OD), and 45 mmHg Oculus Sinister (OD). He underwent trabeculectomy in his left eye in 2002. In 2007, his best corrected visual acuity (BCVA) in both eyes was 20/40 in the right eye and light perception in the left eye. The optic disc showed characteristic glaucomatous changes with cup/disc ratios of 0.9 in the right eye and 1.0 in the left eye. His IOP was maintained between 20 and 24 mmHg in both eyes under antiglaucoma medication. Global indices of the visual field were a mean deviation (MD) of -7.48 dB by the Humphrey field analyzer in the right eye. The visual fields of the left eye could not be determined.
###end p 25
###begin title 26
Case 2 (p.Ala363Thr)
###end title 26
###begin p 27
###xml 91 99 91 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 593 601 593 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 25 30 <span type="species:ncbi:9606">woman</span>
Case 2 was a 60-year-old woman who was diagnosed with POAG in 1970 at the age of 24 years (Figure 1). She underwent trabeculectomy four times in her right eye and twice in her left eye from 1980 to 1981. In 1993, the visual acuity of her right eye and left eye was hand motion and counting finger, respectively. The optic discs had the characteristic changes of glaucoma with a cup/disc ratio of 1.0 OD and 0.9 OS. Her IOP was maintained between 15 and 18 mmHg in both eyes with antiglaucoma medication. Her sisters and brother also had glaucoma that was diagnosed before the age of 40 years (Figure 1), but no further medical record and no blood sample was available.
###end p 27
###begin p 28
###xml 56 59 <span type="species:ncbi:9606">men</span>
###xml 101 106 <span type="species:ncbi:9606">women</span>
Pedigree of Case 2. Solid squares indicate the affected men, and solid circles indicate the affected women. An arrow points to the proband. The gray square indicates the ocular hypertension and glaucoma suspect. The family included six affected individuals.
###end p 28
###begin p 29
###xml 506 510 506 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
The daughter of the proband was first examined for glaucoma in 1999 at the age of 24. Her BCVA was 30/20 Oculus Uterque (OU). Her IOP were 22 mmHg in both eyes. The optic disc was excavated with the cup/disc ratio of 0.8 in both eyes. Automated static perimetry (Humphrey; program 30-2) revealed a nasal step. Treatment was started with topical antiglaucomatous medications, and her IOP was maintained between 16 and 19 mmHg. Her father and sister were also examined and found not to have any mutations in MYOC.
###end p 29
###begin title 30
Case 3 (p.Ala363Thr)
###end title 30
###begin p 31
###xml 132 140 132 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 5 12 <span type="species:ncbi:9606">patient</span>
###xml 31 36 <span type="species:ncbi:9606">woman</span>
This patient was a 65-year-old woman diagnosed with POAG at the age of 44 years. Her brother had also been diagnosed with glaucoma (Figure 2) at the age of 48. As for her mother, no medical record was available regarding the age at diagnosis.
###end p 31
###begin p 32
Pedigree of Case 3. Solid circles indicate the proband and affected mother, and the solid square indicates the affected brother. The white square indicates the father, who is an unaffected subject.
###end p 32
###begin p 33
Her IOP at the time of diagnosis was 22-24 mmHg in both eyes. Her BCVA was 20/20 OU. The optic disc showed the characteristic glaucomatous changes in the right eye with a cup/disc ratio of 0.9-1.0, but the ratio was 0.2 in the left eye. Her IOP was maintained around 20 mmHg in both eyes with antiglaucoma medication. She did not undergo glaucoma surgery. In 2007, the optic disc showed optic atrophy with the full cupping in both eyes. Her visual acuity was hand motion in the right eye and 20/200 in the left eye. Goldmann perimetry showed paracentral residual visual fields in the right eye and absolute scotomas in more than one quadrant in the left eye. The proband and her brother were found to have the same p.Arg363Thr mutation.
###end p 33
###begin title 34
Discussion
###end title 34
###begin p 35
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 516 517 516 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
###xml 189 197 <span type="species:ncbi:9606">patients</span>
###xml 238 246 <span type="species:ncbi:9606">patients</span>
###xml 438 446 <span type="species:ncbi:9606">patients</span>
Our analyses detected two variants of MYOC in our Japanese patients with POAG. A novel MYOC variant, p.Gln297His, and a variant, p.Arg363Thr [19,24], which was reported earlier in Japanese patients, were found. The phenotypes of our POAG patients with the two variants were moderate to high IOP, aggressive course without treatment, poor response to topical medication, and moderate response to filtration surgery. The phenotype in these patients is consistent with the phenotype presented for other GLC1A families [3,27-33].
###end p 35
###begin p 36
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 399 407 399 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 412 420 412 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 427 431 427 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 503 511 503 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
###xml 701 705 701 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 21 29 <span type="species:ncbi:9606">patients</span>
###xml 460 466 <span type="species:ncbi:9606">humans</span>
###xml 468 479 <span type="species:ncbi:9598">chimpanzees</span>
###xml 481 485 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
###xml 487 491 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 497 501 <span type="species:ncbi:9615">dogs</span>
In general, Japanese patients with POAG caused by a MYOC mutation such as p.Pro370Leu [16] and p.Thr448Pro [17,23] show early-onset at the age 40 years or younger. On the other hand, the POAG caused by a p.Ile360Asn [21] mutation has a late-onset phenotype as it is with the p.Gln368Stop mutation found in Western countries [12,34]. The p.Ala363Thr was segregated as an autosomal dominant mutation (Figure 1 and Figure 2), and MYOC orthologs were conserved in humans, chimpanzees, rats, mice, and dogs (Figure 3). p.Gln297His alters the amino acid sequence on the charge (neutral to basic), and p.Ala363Thr alters the amino acid sequence on the polarity (nonpolar to polar). Thus, the conservation of MYOC orthologs and changes that alter the charge and polarity can be considered to be probable disease-causing mutations. However, the subject who had the p.Gln297His mutation did not show family history.
###end p 36
###begin p 37
###xml 204 210 <span type="species:ncbi:9606">humans</span>
###xml 212 223 <span type="species:ncbi:9598">chimpanzees</span>
###xml 225 229 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
###xml 231 235 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 241 245 <span type="species:ncbi:9615">dogs</span>
Multiple amino acid alignments and evolutionary conservation of p.Gln297 and p.Arg363 of MYOC variants. Protein domains of MYOC are shown. Gln297 and Arg363 (underlined) are conserved among five species, humans, chimpanzees, rats, mice, and dogs.
###end p 37
###begin p 38
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 156 164 156 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4</xref>
###xml 182 186 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 471 473 471 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
About 90% of the mutations are clustered in exon 3 of MYOC in different ethnic populations [15], and this incidence is the same in the Japanese population (Figure 4). In this study, MYOC mutations were found at the rate of 3/136 (2.2%), which is approximately the same as previous reports on the Japanese and other ethnic populations [15,19]. The p.Ala363Thr mutation was found in another Japanese population and thus may be useful to examine in genetic screening tests [19,24].
###end p 38
###begin p 39
Mutation spectrum found in Japanese individuals. The black boxes indicate the three exons. Nine out of 11 mutations are located in exon 3, the olfactomedin-like domain. The two underlined mutations were found in this study.
###end p 39
###begin p 40
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 236 240 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
Identification of MYOC mutations will allow early detection even before the elevation of IOP or the irreversible visual impairment due to damage of the optic nerve. More studies of the function and genotype-phenotype correlation of the MYOC gene are required to determine the pathophysiology of POAG.
###end p 40
###begin title 41
Acknowledgments
###end title 41
###begin p 42
This study was supported in part by a Grant-In-Aid for Scientific Research from the Ministry of Education, Science, and Culture of the Japanese Government (N.F.; C-18591905), Tokyo, Japan. This study was supported by a grant to N.F. from the Imai Memorial Fund for Glaucoma Research. The authors thank Dr. Duco I. Hamasaki for editing the manuscript.
###end p 42
###begin title 43
References
###end title 43
###begin article-title 44
Molecular genetics of the glaucomas: mapping of the first five "GLC" loci.
###end article-title 44
###begin article-title 45
Recent advances in molecular genetics of glaucomas.
###end article-title 45
###begin article-title 46
 Clinical features and linkage analysis of a family with autosomal dominant juvenile glaucoma.
###end article-title 46
###begin article-title 47
WLM A. Genetic linkage of familial open angle glaucoma to chromosome 1q21-31.
###end article-title 47
###begin article-title 48
Identification of a gene that causes primary open angle glaucoma.
###end article-title 48
###begin article-title 49
Adult-onset primary open-angle glaucoma caused by mutations in optineurin.
###end article-title 49
###begin article-title 50
Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1.
###end article-title 50
###begin article-title 51
Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain in TIGR in familial open-angle glaucoma.
###end article-title 51
###begin article-title 52
Mutation in TIGR gene in familial open angle glaucoma in Japan.
###end article-title 52
###begin article-title 53
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Prevalence of mutations in TIGR/Myocilin in patients with adult and juvenile primary open-angle glaucoma.
###end article-title 53
###begin article-title 54
GLC1A mutations point to regions of potential functional importance on the TIGR/MYOC protein.
###end article-title 54
###begin article-title 55
Gln368STOP myocilin mutation in families with late-onset primary open-angle glaucoma.
###end article-title 55
###begin article-title 56
Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A).
###end article-title 56
###begin article-title 57
Novel mutations in the TIGR gene in early and late onset open angle glaucoma.
###end article-title 57
###begin article-title 58
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Analysis of myocilin mutations in 1703 glaucoma patients from five different populations.
###end article-title 58
###begin article-title 59
Clinical phenotype of a japanese family with primary open angle glaucoma caused by a Pro370Leu mutation in the MYOC/TIGR gene.
###end article-title 59
###begin article-title 60
Detection of a new TIGR gene mutation in a japanese family with primary open angle glaucoma.
###end article-title 60
###begin article-title 61
Age-dependent prevalence of mutations at the GLC1A locus in primary open-angle glaucoma.
###end article-title 61
###begin article-title 62
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Novel mutations in the myocilin gene in Japanese glaucoma patients.
###end article-title 62
###begin article-title 63
Founder TIGR/myocilin mutations for glaucoma in the Quebec population.
###end article-title 63
###begin article-title 64
Two families with primary open-angle glaucoma associated with myocilin gene mutations.
###end article-title 64
###begin article-title 65
###xml 42 50 <span type="species:ncbi:9606">patients</span>
Variants of the myocilin gene in Japanese patients with normal-tension glaucoma.
###end article-title 65
###begin article-title 66
###xml 49 57 <span type="species:ncbi:9606">patients</span>
Novel MYOC gene mutation, Phe369Leu, in Japanese patients with primary open-angle glaucoma detected by denaturing high-performance liquid chromatography.
###end article-title 66
###begin article-title 67
Clinical phenotype of a Japanese family with primary open-angle glaucoma caused by a Ala 363 Thr mutation in the MYOC gene.
###end article-title 67
###begin article-title 68
A novel myosin-like protein (Myocilin) expressed in the connecting cilium of the photoreceptor: molecular cloning, tissue expression, and chromosomal mapping.
###end article-title 68
###begin article-title 69
###xml 56 61 <span type="species:ncbi:9606">human</span>
Cloning and characterization of subtracted cDNAs from a human ciliary body library encoding TIGR, a protein involved in juvenile open angle glaucoma with homology to myosin and olfactomedin.
###end article-title 69
###begin article-title 70
Mapping of a gene for autosomal dominant juvenile-onset open-angle glaucoma to chromosome1q.
###end article-title 70
###begin article-title 71
Confirmation of linkage to 1q21-31 in a Danish autosomal dominant juvenile-onset glaucoma family and evidence of genetic heterogeneity.
###end article-title 71
###begin article-title 72
A common gene for juvenile and adult-onset primary open-angle glaucoma confined on chromosome 1q.
###end article-title 72
###begin article-title 73
Clinical features of five pedigrees genetically linked to the juvenile glaucoma locus on chromosome 1q21-31.
###end article-title 73
###begin article-title 74
Clinical phenotype of juvenile-onset primary open-angle glaucoma linked to chromosome 1q.
###end article-title 74
###begin article-title 75
Age-dependent penetrance and mapping of the locus for juvenile and early-onset open-angle glaucoma on chromosome 1q (GLC1A) in a French family.
###end article-title 75
###begin article-title 76
Juvenile glaucoma linked to the GLC1A gene on chromosome 1q in a Panamanian family.
###end article-title 76
###begin article-title 77
Myocilin Gln368stop mutation and advanced age as risk factors for late-onset primary open-angle glaucoma.
###end article-title 77

